Oppenheimer & Co
BMEZ icon

Oppenheimer & Co’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Oppenheimer & Co’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.29M Buy
197,033
+96,920
+97% +$1.57M 0.03% 469
2026
Q2 		$1.54M Buy
100,113
+911
+0.9% +$13.1K 0.02% 754
2026
Q1 		$1.42M Buy
+99,202
New +$1.47M 0.02% 725
2025
Q4 		– Sell
-104,131
Closed -$1.5M – 1595
2025
Q3 		$1.5M Buy
104,131
+23,660
+29% +$336K 0.02% 712
2025
Q2 		$1.15M Sell
80,471
-31,365
-28% -$448K 0.02% 794
2025
Q1 		$1.67M Sell
111,836
-2,024
-2% -$31.7K 0.03% 595
2024
Q4 		$1.64M Sell
113,860
-90,494
-44% -$1.4M 0.02% 606
2024
Q3 		$3.24M Buy
204,354
+1,153
+0.6% +$18.2K 0.05% 396
2024
Q2 		$3.12M Buy
203,201
+57,933
+40% +$878K 0.05% 392
2024
Q1 		$2.38M Buy
145,268
+68,569
+89% +$1.08M 0.04% 462
2023
Q4 		$1.12M Buy
76,699
+1,536
+2% +$21.4K 0.02% 667
2023
Q3 		$1.08M Buy
75,163
+9,082
+14% +$142K 0.02% 647
2023
Q2 		$1.09M Buy
66,081
+21,815
+49% +$356K 0.02% 675
2023
Q1 		$740K Buy
44,266
+4,263
+11% +$68.7K 0.02% 803
2022
Q4 		$617K Buy
40,003
+31
+0.1% +$480 0.01% 852
2022
Q3 		$597K Buy
39,972
+4,395
+12% +$72.7K 0.01% 829
2022
Q2 		$585K Sell
35,577
-1,066
-3% -$18.3K 0.01% 862
2022
Q1 		$735K Buy
36,643
+3,519
+11% +$73.1K 0.01% 861
2021
Q4 		$840K Buy
33,124
+6,588
+25% +$170K 0.01% 850
2021
Q3 		$716K Buy
26,536
+181
+0.7% +$5.18K 0.01% 869
2021
Q2 		$762K Buy
26,355
+189
+0.7% +$5.23K 0.01% 854
2021
Q1 		$688K Buy
26,166
+4,986
+24% +$141K 0.01% 838
2020
Q4 		$607K Buy
21,180
+1,023
+5% +$27.2K 0.01% 818
2020
Q3 		$481K Buy
20,157
+1,437
+8% +$33.1K 0.01% 815
2020
Q2 		$391K Buy
+18,720
New +$369K 0.01% 882

Other funds holding BMEZ

Apollon Wealth Management
Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return
Indivisible Partners
Indivisible Partners Clearwater, Florida $2.18B AUM 33.61% 1-Year Est. Return
Brown, Lisle/Cummings
Brown, Lisle/Cummings Providence, Rhode Island $453M AUM 20.23% 1-Year Est. Return
NWF Advisory Services
NWF Advisory Services Los Angeles, California $1.07B AUM 35.62% 1-Year Est. Return
PMG Family Office
PMG Family Office Plano, Texas $108M AUM 8.93% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Chapin Davis
Chapin Davis Baltimore, Maryland $520M AUM 117.57% 1-Year Est. Return
SeaCrest Wealth Management
SeaCrest Wealth Management Purchase, New York $883M AUM 33.97% 1-Year Est. Return
Kathmere Capital Management
Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return

Oppenheimer & Co's BMEZ Position: Q3 2026 in Review

Oppenheimer & Co increased its BlackRock Health Sciences Trust II (BMEZ) stake by 97% in Q3 2026, buying an estimated $1.57M and bringing the position to 197,033 shares worth $3.29M. The position accounts for 0.03% of the portfolio, ranked #469.

Oppenheimer & Co first reported a position in BMEZ in Q2 2020 and has held it in 25 quarters since. 15 funds tracked by Wall St. Rank hold BMEZ as of Q3 2026.

  • Oppenheimer & Co held 197,033 shares of BlackRock Health Sciences Trust II worth $3.29M as of Q3 2026.
  • Oppenheimer & Co bought 96,920 BlackRock Health Sciences Trust II shares in Q3 2026, an estimated $1.57M.
  • BlackRock Health Sciences Trust II made up 0.03% of Oppenheimer & Co's portfolio in Q3 2026, its #469 holding.
  • Oppenheimer & Co first reported a position in BlackRock Health Sciences Trust II in Q2 2020 and has held it in 25 quarters since.
  • 15 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2026.

Based on Oppenheimer & Co's 13F filing for Q3 2026, filed 26 Oct 2026.